These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15567286)
1. N4-alkyloxycarbonyl derivatives of cytosine: physicochemical characterisation, and cytosine regeneration rates and release from alginic acid gels. Petersson K; Pedersen BT; Staerk D; Krogfelt KA; Larsen C Eur J Pharm Sci; 2004 Dec; 23(4-5):337-45. PubMed ID: 15567286 [TBL] [Abstract][Full Text] [Related]
2. Alginate-based in situ gelling suspensions and emulsions comprising N4-alkyloxycarbonyl derivatives of cytosine: zero-order release and effect of physicochemical properties. Petersson K; Larsen C Drug Dev Ind Pharm; 2005 Aug; 31(7):667-75. PubMed ID: 16207614 [TBL] [Abstract][Full Text] [Related]
3. Properties of calcium-induced gel beads prepared with alginate and hydrolysates. Murata Y; Jinno D; Kofuji K; Kawashima S Chem Pharm Bull (Tokyo); 2004 May; 52(5):605-7. PubMed ID: 15133215 [TBL] [Abstract][Full Text] [Related]
4. Dual responsive aerogel made from thermo/pH sensitive graft copolymer alginate-g-P(NIPAM-co-NHMAM) for drug controlled release. Shao L; Cao Y; Li Z; Hu W; Li S; Lu L Int J Biol Macromol; 2018 Jul; 114():1338-1344. PubMed ID: 29601880 [TBL] [Abstract][Full Text] [Related]
5. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices. Nokhodchi A; Tailor A Farmaco; 2004 Dec; 59(12):999-1004. PubMed ID: 15598436 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of new derivatives of alginic acid and evaluation of their iron(III)-crosslinked beads as potential controlled release matrices. Abulateefeh SR; Khanfar MA; Al Bakain RZ; Taha MO Pharm Dev Technol; 2014 Nov; 19(7):856-67. PubMed ID: 24032476 [TBL] [Abstract][Full Text] [Related]
8. Trivalent ion cross-linked pH sensitive alginate-methyl cellulose blend hydrogel beads from aqueous template. Banerjee S; Singh S; Bhattacharya SS; Chattopadhyay P Int J Biol Macromol; 2013 Jun; 57():297-307. PubMed ID: 23537798 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of OSA/CS core-shell microgel: in vitro drug release and degradation properties. Chen C; Gao C; Liu M; L S; Yu C; Ma S; Wang J; Cui G J Biomater Sci Polym Ed; 2013; 24(9):1127-39. PubMed ID: 23683042 [TBL] [Abstract][Full Text] [Related]
10. In situ stabilization of chromium(VI) in polluted soils using organic ligands: the role of galacturonic, glucuronic and alginic acids. Kantar C; Cetin Z; Demiray H J Hazard Mater; 2008 Nov; 159(2-3):287-93. PubMed ID: 18387738 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterisation of gastroretentive alginate beads for targeting H. pylori. Adebisi AO; Conway BR J Microencapsul; 2014; 31(1):58-67. PubMed ID: 23795906 [TBL] [Abstract][Full Text] [Related]
12. Effect of charge and size of diffusing probe on the diffusion through calcium alginate gel matrices. Holte Ø; Tønnesen HH; Karlsen J Pharmazie; 2007 Dec; 62(12):914-8. PubMed ID: 18214342 [TBL] [Abstract][Full Text] [Related]
16. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy. Ishak RA; Awad GA; Mortada ND; Nour SA J Control Release; 2007 Jun; 119(2):207-14. PubMed ID: 17412443 [TBL] [Abstract][Full Text] [Related]
17. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients. Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404 [TBL] [Abstract][Full Text] [Related]
18. Effect of composition on the physicochemical properties and active substance release from gelatin-alginate sponge. Haznar D; Pluta J Polim Med; 2003; 33(4):17-27. PubMed ID: 15058110 [TBL] [Abstract][Full Text] [Related]
19. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment. Mooranian A; Negrulj R; Al-Sallami HS; Fang Z; Mikov M; Golocorbin-Kon S; Fakhoury M; Arfuso F; Al-Salami H J Microencapsul; 2015; 32(2):151-6. PubMed ID: 25265061 [TBL] [Abstract][Full Text] [Related]
20. Galactose-substituted alginate: preliminary characterization and study of gelling properties. Donati I; Vetere A; Gamini A; Skjåk-Braek G; Coslovi A; Campa C; Paoletti S Biomacromolecules; 2003; 4(3):624-31. PubMed ID: 12741778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]